Viewing Study NCT06388551


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-01-02 @ 1:19 PM
Study NCT ID: NCT06388551
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-29
First Post: 2024-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017
Sponsor: Luye Pharma Group Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module